Cargando…

Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ Agonist in Diabetic Rat

We investigated effects on glucose and lipid metabolism in combination of JTT-130, a novel intestine-specific microsomal triglyceride transfer protein (MTP) inhibitor, and pioglitazone, peroxisome proliferator-activated receptor (PPAR) γ agonist. Male Zucker diabetic fatty rats were divided into 4 g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakata, Shohei, Mera, Yasuko, Kuroki, Yukiharu, Nashida, Reiko, Kakutani, Makoto, Ohta, Takeshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977080/ https://www.ncbi.nlm.nih.gov/pubmed/24772450 http://dx.doi.org/10.1155/2014/890639

Ejemplares similares

JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Improves Hyperglycemia and Dyslipidemia Independent of Suppression of Food Intake in Diabetic Rats
por: Sakata, Shohei, et al.
Publicado: (2014)

JTT-130, a Novel Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein, Reduces Food Preference for Fat
por: Mera, Yasuko, et al.
Publicado: (2014)

Multiple functions of microsomal triglyceride transfer protein
por: Hussain, M Mahmood, et al.
Publicado: (2012)

The crystal structure of human microsomal triglyceride transfer protein
por: Biterova, Ekaterina I., et al.
Publicado: (2019)

Microsomal triglyceride transfer protein contributes to lipid droplet maturation in adipocytes
por: Swift, Larry L., et al.
Publicado: (2017)

Generation of hepatoma cell lines deficient in microsomal triglyceride transfer protein
por: Anaganti, Narasimha, et al.
Publicado: (2022)

Intestine-Specific Deletion of Microsomal Triglyceride Transfer Protein Increases Mortality in Aged Mice
por: Liang, Zhe, et al.
Publicado: (2014)

A point mutation decouples the lipid transfer activities of microsomal triglyceride transfer protein
por: Wilson, Meredith H., et al.
Publicado: (2020)

Cardiac Expression of Microsomal Triglyceride Transfer Protein Is Increased in Obesity and Serves to Attenuate Cardiac Triglyceride Accumulation
por: Bartels, Emil D., et al.
Publicado: (2009)

Identification of a Novel Transcript and Regulatory Mechanism for Microsomal Triglyceride Transfer Protein
por: Suzuki, Takashi, et al.
Publicado: (2016)

Microsomal triglyceride transfer protein in the ectoparasitic crustacean salmon louse (Lepeophtheirus salmonis)
por: Khan, Muhammad Tanveer, et al.
Publicado: (2017)

Lomitapide–a Microsomal Triglyceride Transfer Protein Inhibitor for Homozygous Familial Hypercholesterolemia
por: Stefanutti, Claudia
Publicado: (2020)

An improved assay to measure the phospholipid transfer activity of microsomal triglyceride transport protein
por: Anaganti, Narasimha, et al.
Publicado: (2021)

Expression of microsomal triglyceride transfer protein in lipoprotein-synthesizing tissues of the developing chicken embryo()
por: Eresheim, Christine, et al.
Publicado: (2014)

Microsomal triglyceride transfer protein lipidation and control of CD1d on antigen-presenting cells
por: Dougan, Stephanie K., et al.
Publicado: (2005)

Discovery of Novel Splice Variants and Regulatory Mechanisms for Microsomal Triglyceride Transfer Protein in Human Tissues
por: Suzuki, Takashi, et al.
Publicado: (2016)

The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis
por: Li, Jingjing, et al.
Publicado: (2021)

A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d
por: Sagiv, Yuval, et al.
Publicado: (2007)

Supplementary site interactions are critical for the regulation of microsomal triglyceride transfer protein by microRNA-30c
por: Soh, James, et al.
Publicado: (2013)

JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs
por: Aggarwal, Dimple, et al.
Publicado: (2005)

Microsomal Triglyceride Transfer Protein (MTP) Associates with Cytosolic Lipid Droplets in 3T3-L1 Adipocytes
por: Love, Joseph D., et al.
Publicado: (2015)

Inhibition of hepatic microsomal triglyceride transfer protein – a novel therapeutic option for treatment of homozygous familial hypercholesterolemia
por: Vuorio, Alpo, et al.
Publicado: (2014)

Magnesium accumulation upon cyclin M4 silencing activates microsomal triglyceride transfer protein improving NASH
por: Simón, Jorge, et al.
Publicado: (2021)

Hepatic steatosis in hepatitis C is a storage disease due to HCV interaction with microsomal triglyceride transfer protein (MTP)
por: Mirandola, Silvia, et al.
Publicado: (2010)

Suppression of Rat Oral Carcinogenesis by Agonists of Peroxisome Proliferator Activated Receptor γ
por: McCormick, David L., et al.
Publicado: (2015)

Synergy between peroxisome proliferator‐activated receptor γ agonist and radiotherapy in cancer
por: Huang, Guodong, et al.
Publicado: (2018)

Genetic variation in the microsomal triglyceride transfer protein (−493G/T) is associated with hepatic steatosis in patients infected with hepatitis C virus
por: Magri, Mariana Cavalheiro, et al.
Publicado: (2017)

17β-Estradiol-Induced Conformational Changes of Human Microsomal Triglyceride Transfer Protein: A Computational Molecular Modelling Study
por: Yang, Yong-Xiao, et al.
Publicado: (2021)

A Role for Peroxisome Proliferator-Activated Receptor Gamma Agonists in Counteracting the Degeneration of Cardiovascular Grafts
por: Assmann, Anna Kathrin, et al.
Publicado: (2022)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives
por: Chiarelli, Francesco, et al.
Publicado: (2008)

Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma
por: BO, QI-FU, et al.
Publicado: (2015)

Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
por: Heudobler, Daniel, et al.
Publicado: (2018)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

RNA helicase DDX3 maintains lipid homeostasis through upregulation of the microsomal triglyceride transfer protein by interacting with HNF4 and SHP
por: Tsai, Tsung-Yuan, et al.
Publicado: (2017)

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
por: Wang, Limei, et al.
Publicado: (2014)

Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis
por: Suzuki, Shugo, et al.
Publicado: (2016)

Peroxisome proliferator-activated receptor γ agonist suppresses mast cell maturation and induces apoptosis
por: Zhang, Yu, et al.
Publicado: (2017)

Microsomal triglyceride transfer protein -164 T > C gene polymorphism and risk of cardiovascular disease: results from the EPIC-Potsdam case-cohort study
por: di Giuseppe, Romina, et al.
Publicado: (2013)

Mice subjected to aP2-Cre mediated ablation of microsomal triglyceride transfer protein are resistant to high fat diet induced obesity
por: Bakillah, Ahmed, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h6a2bac7g5h284j5b5nsu88qlu